Literature DB >> 498170

Pharmacokinetics and metabolism of chlorambucil in patients with malignant disease.

A McLean, R L Woods, D Catovsky, P Farmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 498170     DOI： 10.1016/s0305-7372(79)80008-0

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  12 in total

Review 1.  Mass balance studies, with a focus on anticancer drugs.

Authors:  Jan H Beumer; Jos H Beijnen; Jan H M Schellens
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Inter- and intraindividual differences in oral chlorambucil pharmacokinetics.

Authors:  P Hartvig; B Simonsson; G Oberg; I Wallin; H Ehrsson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat.

Authors:  N H Greig; D J Sweeney; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustards.

Authors:  D Godenèche; J C Madelmont; M F Moreau; R Plagne; G Meyniel
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

5.  The clinical pharmacology of chlorambucil and prednimustine.

Authors:  D R Newell; A H Calvert; K R Harrap; T J McElwain
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

6.  Effect of food on pharmacokinetics of chlorambucil and its main metabolite, phenylacetic acid mustard.

Authors:  H Ehrsson; I Wallin; B Simonsson; P Hartvig; G Oberg
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Chlorambucil central nervous toxicity: a significant side effect of chlorambucil therapy in childhood nephrotic syndrome.

Authors:  F Ichida; T Konishi; R Asada; M Yamatani; M Konda; M Tani; T Tanizawa; Y Suzuki; T Okada; S Kyotani
Journal:  Eur J Pediatr       Date:  1985-09       Impact factor: 3.183

8.  Studies on the pharmacokinetics of chlorambucil and prednimustine in man.

Authors:  D R Newell; A H Calvert; K R Harrap; T J McElwain
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

9.  A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patients.

Authors:  L Bastholt; C J Johansson; P Pfeiffer; L Svensson; S A Johansson; P O Gunnarsson; H Mouridsen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

10.  Physicochemical and pharmacokinetic parameters of seven lipophilic chlorambucil esters designed for brain penetration.

Authors:  N H Greig; S Genka; E M Daly; D J Sweeney; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.